ALB and congestive heart failure: By the ROC curve, we found that 37.45 g/L was the optimal cut-off point for albumin to predict the therapeutic outcomes of patient with CHF, which suggested that albumin supplementation was conducive to improve therapeutic outcomes for the CHF patient with albumin <37.45 g/L at admission.